Zimmer snaps up ORTHOsoft in Can$50m deal
This article was originally published in Clinica
Zimmer is set to add to further expand its orthopaedic portfolio with the acquisition of computer assisted surgery (CAS) specialist ORTHOsoft. Zimmer has signed an agreement that will see it purchase all outstanding ORTHOsoft shares for Can$1.10 ($1) per share, giving the transaction a total value of Can$50m.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.